There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K39/00
Jump to navigation
Jump to search
Subcategories
This category has the following 55 subcategories, out of 55 total.
A
B
D
E
F
G
H
I
J
L
M
N
O
P
R
S
W
X
Y
Z
Pages in category "A61K39/00"
The following 156 pages are in this category, out of 156 total.
1
- 17760479. COMPOSITIONS AND METHODS COMPRISING SPLICING-DERIVED ANTIGENS FOR TREATING CANCER simplified abstract (The Regents of the University of California)
- 17768217. TRANSPLANTED CELL PROTECTION VIA Fc SEQUESTRATION simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 17905830. IN-VITRO TRANSCRIPT MRNA AND PHARMACEUTICAL COMPOSITION COMPRISING SAME simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 17995083. Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems simplified abstract (The Regents of the University of California)
- 18013864. METHODS TO GLYCOENGINEER PROTEINS simplified abstract (THE JOHNS HOPKINS UNIVERSITY)
- 18260377. ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY simplified abstract (The Regents of the University of California)
- 18269803. NK CELL ENGAGER MOLECULES AND METHODS OF USE simplified abstract (REGENTS OF THE UNIVERSITY OF MINNESOTA)
- 18271366. MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT OF DISEASE simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18274145. TREATMENT OF NEUROENDOCRINE CANCERS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18274307. Regulation of Butyrophilin subfamily 3 member A1 (BTN3A1, CD277) simplified abstract (The Regents of the University of California)
- 18274979. IMMUNE RECEPTORS WITH SYNTHETIC CO-STIMULATORY DOMAINS simplified abstract (The Regents of the University of California)
- 18277897. COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18283042. Highly Attenuated Replication-Competent Recombinant Poxvirus As A Vaccine Platform And Methods Of Use simplified abstract (ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY)
- 18290730. DE-CLUSTERING INHIBITORS OF PTPRA (The Regents of the University of California)
- 18294767. METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18295036. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation)
- 18381258. CAR-T CONSTRUCTS COMPRISING A NOVEL CD19 BINDER COMBINED WITH IL18 AND METHODS OF USING THE SAME simplified abstract (The Trustees of the University of Pennsylvania)
- 18412280. FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18420510. ISOFORM-SELECTIVE ANTI-TGF-BETA ANTIBODIES AND METHODS OF USE simplified abstract (GENENTECH, INC.)
- 18438746. METHODS OF TREATING CANCER PAIN BY ADMINISTERING A PD-1 INHIBITOR simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18443314. MICROPOROUS ANNEALED PARTICLE GEL SYSTEM (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18448665. PREPARATION METHOD OF CITRULLINATED VIMENTIN ANTIGEN-SPECIFIC IMMUNE TOLEROGENIC DENDRITIC CELLS, AND USES THEREOF simplified abstract (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18454684. CHIMERIC ANTIGEN RECEPTORS THAT BIND PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME)/HLA-A2 TO TREAT CANCER simplified abstract (Fred Hutchinson Cancer Center)
- 18476573. COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND APOPTOTIC CANCER CELL VACCINATION simplified abstract (Novocure GmbH)
- 18477010. COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS simplified abstract (Novocure GmbH)
- 18488913. MICROBIAL CONSORTIUM AND USES THEREOF simplified abstract (The Regents of the University of California)
- 18525612. Active Agent Delivery Devices and Methods of Using the same simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18547445. IN VIVO CRISPR SCREENING SYSTEM FOR DISCOVERING THERAPEUTIC TARGETS IN CD8 T CELLS (The Trustees of the University of Pennsylvania)
- 18548481. TARGETING T REGULATORY CELLS TO ISLET CELLS TO STALL OR REVERSE TYPE 1 DIABETES simplified abstract (The Trustees of the University of Pennsylvania)
- 18549503. SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VIRAL DELIVERY OF ORTHOGONAL IL-2 simplified abstract (The Regents of the University of California)
- 18552131. HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS simplified abstract (The Regents of the University of California)
- 18552141. SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION simplified abstract (The Regents of the University of California)
- 18552478. ENHANCING T CELL FUNCTION THROUGH THE USE OF PROXIMAL SIGNALING MOLECULES simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18554979. CANCER PROPHYLAXIS AND THERAPY USING TARGETED VIRAL NANOPARTICLES simplified abstract (The Regents of the University of California)
- 18558882. DOUBLE SIDED CHIMERIC ANTIGEN RECEPTOR (CAR) ENGINEERED CELL MEMBRANE BASED DRUG DELIVERY SYSTEMS simplified abstract (BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM)
- 18561331. METHODS OF TREATMENT OF CANCER PATIENTS HAVING ALTERED SETD2 BIOMARKER WITH A PD-1 ANTAGONIST simplified abstract (Merck Sharp & Dohme LLC)
- 18579425. HUMAN IPSC-DERIVED MACROPHAGE simplified abstract (The Regents of the University of California)
- 18594234. ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18594291. COMPOSITIONS FOR USE IN TREATMENT OF CHLAMYDIA simplified abstract (SANOFI)
- 18596375. CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR simplified abstract (The Regents of the University of California)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (The Trustees of the University of Pennsylvania)
- 18620748. Use of CD2/5/7 Knock-Out Anti-CD2/5/7 Chimeric Antigen Receptor T cells Against T Cell Lymphomas and Leukemias simplified abstract (The Trustees of the University of Pennsylvania)
- 18621627. METHODS FOR DESIGNING IMMUNOTHERAPIES AND TREATMENTS USING SAME (The Regents of the University of California)
- 18629296. VACCINE ADJUVANTS, TRANSFECTION REAGENTS, AND METHODS OF USING THE SAME simplified abstract (WISCONSIN ALUMNI RESEARCH FOUNDATION)
- 18629922. Kaposi sarcoma associated herpesvirus gene function simplified abstract (The Regents of the University of California)
- 18630437. ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS simplified abstract (Merck Sharp & Dohme LLC)
- 18643312. BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract (The Regents of the University of California)
- 18647560. SYSTEMS AND METHODS TO IDENTIFY MHC-ASSOCIATED ANTIGENS FOR THERAPEUTIC INTERVENTION simplified abstract (GENENTECH, INC.)
- 18648653. DUAL SPECIFIC ANTIBODIES simplified abstract (GENENTECH, INC.)
- 18656957. HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION simplified abstract (Hoffmann-La Roche Inc.)
- 18659241. COMBINATION THERAPY WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE AND A BCL-2 INHIBITOR simplified abstract (GENENTECH, INC.)
- 18667792. H3.3 CTL PEPTIDES AND USES THEREOF (The Regents of the University of California)
- 18681787. METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA simplified abstract (HOFFMANN-LA ROCHE INC.)
- 18728163. BACTERIAL COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMMUNE DISEASES (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18728813. Listeria Variants and Methods of Use Thereof (The Regents of the University of California)
- 18737782. Anti-Trkb Monoclonal Antibodies And Methods Of Use simplified abstract (Regeneron Pharmaceuticals, Inc.)
- 18737807. COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE (The Board of Trustees of the Leland Stanford Junior University)
- 18746810. IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES simplified abstract (Beam Therapeutics Inc.)
- 18748995. NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS simplified abstract (Merck Patent GmbH)
- 18750233. ENHANCED CHIMERIC ANTIGEN RECEPTORS AND USE THEREOF simplified abstract (Board of Regents, The University of Texas System)
- 18762543. ANTI-IgE ANTIBODY THERAPY FOR MULTIPLE FOOD ALLERGIES (Novartis AG)
- 18776496. DISRUPTING TUMOR TISSUES BY TARGETING FIBROBLAST ACTIVATION PROTEIN (FAP) (The Trustees of the University of Pennsylvania)
- 18784586. NEUTRALIZING ANTIBODIES TO THE ALPHA V BETA 8 INTEGRIN COMPLEX FOR IMMUNOTHERAPY (The Regents of the University of California)
- 18792232. CLAUDIN-6 ANTIBODIES AND DRUG CONJUGATES (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18808565. Vaccine Adjuvant (Wisconsin Alumni Research Foundation)
- 18883719. COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS (The Johns Hopkins University)
- 18896693. SYSTEM AND METHOD (KABUSHIKI KAISHA TOSHIBA)
- 18907274. COMPOSITIONS AND METHODS USEFUL IN PROMOTING MILK PRODUCTION (The Regents of the University of California)
- 18914687. PERTUZUMAB VARIANTS AND EVALUATION THEREOF (Genentech, Inc.)
- 18951146. BISPECIFIC HUMANIZED SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47, AND USE THEREOF (SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION)
- 18956269. METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES (Genentech, Inc.)
2
- 20240016787. METHODS FOR TREATMENT OF CANCER AND PHAGOCYTOSIS-DEFICIENCY RELATED DISEASES simplified abstract (RDiscovery, LLC)
- 20240024362. DONOR HEMATOPOIETIC CELL CHIMERISM AND ORGAN AND TISSUE TRANSPLANTATION AND AUTOIMMUNE TOLERANCE simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 20240024443. AUGMENTATION OF SURVIVIN MODIFIED MRNA VACCINE EFFICACY USING DENDRITIC CELLS simplified abstract (Regen Biopharma, Inc.)
- 20240024473. HUMAN CHIMERIC ANTIGEN RECEPTOR NEUTROPHILS, COMPOSITIONS, KITS AND METHODS OF USE simplified abstract (Purdue Research Foundation)
A
- Accessibility patent applications on December 5th, 2024
- Accessibility patent applications on February 6th, 2025
- Amazon technologies, inc. (20250003004). Personalized Longitudinal Analysis of Circulating Material to Monitor and Adapt Neoantigen Cancer Vaccines
- Amazon Technologies, Inc. patent applications on January 2nd, 2025
B
- Beijing Gene MiNK Biotechnology CO.LTD (20250018035). METHOD FOR EFFICIENTLY INFECTING HUMAN NATURAL KILLER CELLS AND OTHER IMMUNE CELLS WITH PSEUDOVIRUS
- Biotechnology patent applications on 13th Sep 2024
- Biotechnology patent applications on 14th Feb 2025
- Biotechnology patent applications on 14th Mar 2025
- Biotechnology patent applications on 23rd Aug 2024
- Biotechnology patent applications on August 15th, 2024
- Biotechnology patent applications on August 22nd, 2024
- Biotechnology patent applications on December 5th, 2024
- Biotechnology patent applications on February 13th, 2025
- Biotechnology patent applications on January 16th, 2025
- Biotechnology patent applications on March 13th, 2025
- Biotechnology patent applications on May 30th, 2024
- Biotechnology patent applications on November 14th, 2024
- Biotechnology patent applications on September 12th, 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 29th, 2024
- Blockchain patent applications on January 18th, 2024
- Blockchain patent applications on January 25th, 2024
C
- CENTRO DE INMUNOLOGIA MOLECULAR (20240299518). METHOD FOR THE TREATMENT OF PATIENTS WITH CARCINOMAS simplified abstract
- CENTRO DE INMUNOLOGIA MOLECULAR (20240374695). VACCINE COMPOSITIONS DEPLETING HEMATOPOIETIC GROWTH FACTORS FOR THE TREATMENT OF INFLAMMATORY DISEASES simplified abstract
- CENTRO DE INMUNOLOGÍA MOLECULAR (20240279348). USE OF MONOCLONAL ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR IN THE TREATMENT OF PATIENTS WITH HYPOXEMIC ACUTE RESPIRATORY FAILURE simplified abstract
- CZ Biohub SF, LLC (20240398929). ENGINEERING ANTIGEN BINDING TO, AND ORIENTATION ON, ADJUVANTS FOR ENHANCED HUMORAL RESPONSES AND IMMUNOFOCUSING
D
F
K
M
T
- The regents of the university of california (20240248080). Kaposi sarcoma associated herpesvirus gene function simplified abstract
- The regents of the university of california (20240252438). Membrane Encapsulated Nanoparticles and Method of Use simplified abstract
- The regents of the university of california (20240252619). Coronavirus Constructs and Vaccines simplified abstract
- The regents of the university of california (20240254219). NOVEL WNT AGONIST ANTIBODIES AND THERAPEUTIC USES THEREOF simplified abstract
- The regents of the university of california (20240261334). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240293463). BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 simplified abstract
- The regents of the university of california (20240293545). Genetically Engineered Phagocytes, and Related Compositions, Vectors, Methods and Systems simplified abstract
- The regents of the university of california (20240299449). ANTI-CD72 NANOBODIES FOR IMMUNOTHERAPY simplified abstract
- The regents of the university of california (20240299545). HYBRID RECEPTORS WITH MULTIPLE TRANSCRIPTIONAL REGULATORS simplified abstract
- The regents of the university of california (20240316197). HUMAN IPSC-DERIVED MACROPHAGE simplified abstract
- The regents of the university of california (20240408137). METHODS FOR MAKING AND USING THERAPEUTIC CELLS
- The regents of the university of california (20240408204). Methods of Treating Lymphoma with a Phagocyte Having a Chimeric Antigen Receptor
- The regents of the university of california (20250000974). COMBINATION OF HUMAN NATURAL KILLER CELLS AND MACROPHAGES FOR CANCER THERAPY
- The regents of the university of california (20250002587). PREVENTION OF POSTERIOR CAPSULAR OPACIFICATION (PCO) WITH INTEGRIN AVB8 BLOCKING ANTIBODY
- The regents of the university of california (20250064871). BACTERIAL COMPOSITIONS AND METHODS FOR TREATING CANCER AND IMMUNE DISEASES
- The regents of the university of california (20250066469). CLAUDIN-6 ANTIBODIES AND DRUG CONJUGATES
- The regents of the university of california (20250066480). METHODS TO ENHANCE EFFICACY OF COMBINED TARGETING OF IMMUNE CHECKPOINT AND MAPK PATHWAYS
- The regents of the university of california (20250082739). METHODS FOR DESIGNING IMMUNOTHERAPIES AND TREATMENTS USING SAME
- The regents of the university of california (20250082741). Listeria Variants and Methods of Use Thereof
- The regents of the university of california (20250090636). H3.3 CTL PEPTIDES AND USES THEREOF
- The regents of the university of california (20250092129). COMPOSITIONS AND METHODS USEFUL IN PROMOTING MILK PRODUCTION
- The regents of the university of california (20250092156). DE-CLUSTERING INHIBITORS OF PTPRA
- The Regents of the University of California patent applications on August 1st, 2024
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on August 8th, 2024
- The Regents of the University of California patent applications on December 12th, 2024
- The Regents of the University of California patent applications on February 13th, 2025
- THE REGENTS OF THE UNIVERSITY OF CALIFORNIA patent applications on February 27th, 2025
- The Regents of the University of California patent applications on January 2nd, 2025
- The Regents of the University of California patent applications on July 25th, 2024
- The Regents of the University of California patent applications on March 13th, 2025
- The Regents of the University of California patent applications on March 20th, 2025
- The Regents of the University of California patent applications on September 12th, 2024
- The Regents of the University of California patent applications on September 26th, 2024
- The Regents of the University of California patent applications on September 5th, 2024
U
- Unknown Organization (20240269260). mRNA-Based Vaccine Composition for Inducing Immune Response Against HIV and HPV simplified abstract
- US Patent Application 18032932. ATTENUATED CANCER CELLS AND METHODS RELATED THERETO simplified abstract
- US Patent Application 18034037. ANTI-DPP6 CHIMERIC ANTIGEN RECEPTOR BEARING REGULATORY T CELLS simplified abstract
